Interleukin (IL) Inhibitors Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global Interleukin (IL) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Interleukin (IL) is a group of naturally occurring proteins. They mediate communication between cells and regulate cell growth, differentiation, and motility. The major factor driving the demand for interleukin (IL) inhibitors is the increasing prevalence of cancer across the globe.
According to the National Cancer
Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be
diagnosed in the US with a mortality rate of 606,520 people in 2020.
Furthermore, there were 18.1 million new cases and 9.5 million cancer-related
mortalities globally in 2018 which is anticipated to rise to 29.5 million and
the number of cancer-related mortalities to 16.4 million by 2040. Hence, the
increasing prevalence of cancer is driving the demand for interleukin (IL) as
it supports immune system cells to grow and divide more quickly, which in turn,
is driving the growth of the market.
To Request a Sample of our Report on Interleukin (IL)
Inhibitors Market:
https://www.omrglobal.com/request-sample/interleukin-il-inhibitors-market
Some major players in the market include Johnson &
Johnson Services, Inc., GlaxoSmithKline, and Novartis International AG, among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in July
2020, Janssen announced the approval of TREMFYA (guselkumab) from the US Food
and Drug Administration (FDA). It is used for the treatment of adult patients
with active psoriatic arthritis (PsA) which selectively inhibits interleukin
(IL)-23.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Johnson
& Johnson Services, Inc., GlaxoSmithKline, and Novartis International AG,
among others.
(Get 15% Discount on Buying this Report)
A
full Report of Interleukin (IL) Inhibitors Market is Available @ https://www.omrglobal.com/industry-reports/interleukin-il-inhibitors-market
Global Interleukin (IL) Market Report by Segment
By Type
• IL-17
• IL-23
• IL-1
• IL-5
• IL-6
• Others
By Application
• Rheumatoid
Arthritis
• Asthma
• Inflammatory
Bowel Disease
• Cancer
• Others
Global Interleukin (IL) Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment